' '
Deutsch | English    

Research Database PMU-SQQUID

SCHARLER CORNELIA
Institute of Experimental and Clinical Cell Therapy
Spinal Cord Injury and Tissue Regeneration Center Salzburg

Publications | Researcher Profile

55 Publications

2019

Unpublished conference presentations

Development of a human 3D vascularized skin organoid model.
Peking, P; Hochreiter, A; Scharler, C; Vári, B; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
ISSCR International Symposium; 20.-22.02.2019; Amsterdam. 2019.
Self-Assembly of human neo-vascularized skin and skin organoids.
Peking, P; Hochreiter, A; Wolf, M; Scharler, C; Vári, B; Krisch, L; Schallmoser, K; Strunk, D
ISSCR Annual Meeting; 26.-29.06.2019; Los Angeles. 2019.
No identical stromal cells: Transcriptomic meta-Analysis Highlights differences between bone marrow-derived mesenchymal stromal/progenitor cells and other stromal cell sources.
Poupardin, R; Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Schallmoser, K; Strunk, D
5th International CCS-Workshop and 15th International CLL-Workshop; 05.-06.04.2019; Fuschl am See. 2019.

2018

Journal Articles

Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes.
Guttmann-Gruber, C; Tockner, B; Scharler, C; Hüttner, C; Common, JE; Tay, ASL; Denil, SLIJ; Klausegger, A; Trost, A; Breitenbach, J; Schnitzhofer, P; Hofbauer, P; Wolkersdorfer, M; Diem, A; Laimer, M; Strunk, D; Bauer, JW; Reichelt, J; Lang, R; Piñón Hofbauer, J;
Sci Rep. 2018; 8(1): 13430
Originalarbeiten (Zeitschrift)
Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells
Oeller, M; Laner-Plamberger, S; Hochmann, S; Ketterl, N; Feichtner, M; Brachtl, G; Hochreiter, A; Scharler, C; Bieler, L; Romanelli, P; Couillard-Despres, S; Russe, E; Schallmoser, K; Strunk, D
THERANOSTICS. 2018; 8(5): 1421-1434.
Originalarbeiten (Zeitschrift)

Unpublished conference presentations

Addressing skin with IVT mRNA.
Hochmann, S; Mittermeir, M; Santic, R; Scharler, C; Russe, E; Scheiblhofer, S; Weiss, R; Mandler, M; Schneeberger, A; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
NO IDENTICAL STROMAL CELLS: HUMAN STROMAL PROGENITORS FROM NON-SKELETAL SOURCES DISPLAY LIMITED CHONDROGENIC POTENTIAL.
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Schmidt-Bleek, K; Ellinghaus, A; Geissler, S; Duda, G; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Development of an iPSC-mediated strategy for skin regeneration.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Development of a human 3D vascularized skin organoid model.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
Development of an iPSC-mediated strategy for skin regeneration.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
2018 ESDR Future Leaders Academy; 03.-05.10.2018; Budapest. 2018.
Development of a human 3D vascularized skin organoid model.
Peking, P; Hochreiter, A; Scharler, C; Wimmer, M; Krisch, L; Wolf, M; Hochmann, S; Schallmoser, K; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
Development of immunosuppressive iPSC-derived stromal cells for tissue regeneration.
Peking, P; Scharler, C; Ketterl, N; Hochreiter, A; Jürchott, K; Höfler, M; Brachtl, G; Wimmer, M; Wolf, M; Hochmann, S; Schallmoser, K; Volk, H-D; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
NO IDENTICAL STROMAL CELLS: TRANSCRIPTOMIC META-ANALYSIS HIGHLIGHTS DIFFERENCES BETWEEN BONE-MARROW-DERIVED MESENCHYMAL STROMAL/PROGENITOR CELLS AND OTHER STROMAL CELL SOURCES.
Poupardin, R; Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Schallmoser, K; Strunk, D
SCI-TReCS Retreat 2018; 13.-14.09.2018; Wagrain. 2018.
NO IDENTICAL STROMAL CELLS: TRANSCRIPTOMIC META-ANALYSIS HIGHLIGHTS DIFFERENCES BETWEEN BONE-MARROW-DERIVED MESENCHYMAL STROMAL/PROGENITOR CELLS AND OTHER STROMAL CELL SOURCES.
Poupardin, R; Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Schallmoser, K; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
Generation of immunosuppressive iPSC-derived stromal cells for tissue regeneration.
Scharler, C; Peking, P; Ketterl, N; Hochreiter, A; Jürchott, K; Höfler, M; Brachtl, G; Wimmer, M; Wolf, M; Hochmann, S; Schallmoser, K; Volk, HD; Strunk, D
26th Annual Congress of the ESGCT; 16.-19.10.2018; Lausanne. 2018.

2017

Conference papers, proceedings, abstracts

Low-dose calcipotriol as a therapeutic option to improve wound healing in epidermolysis bullosa
Gruber, C; Tockner, B; Laimer, M; Scharler, C; Common, JE; Tay, A; Hofbauer, P; Bauer, JW; Hofbauer, JP; Lang, R
J INVEST DERMATOL. 2017; 137(10): S309-S309.
Abstracts (Zeitschrift)
Addressing skin with in vitro transcribed mRNA
Hochmann, S; Mittermeir, M; Santic, R; Scharler, C; Scheiblhofer, S; Russe, E; Weiss, R; Mandler, M; Schneeberger, A; Strunk, D
Human Gene Therapy. 2017; 28: A85-A85.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
No identical stromal cells: Human stromal progenitors from non-skeletal sources display limited chondrogenic potential.
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Schmidt-Bleek, K; Ellinghaus, A; Geissler, S; Duda, G; Strunk, D
Human Gene Therapy. 2017; 28: A84-A84.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Neuroprotective activity of mesenchymal stromal cells and their secreted vesicles in a spinal cord contusion rat model
Romanelli, P; Bieler, L; Scharler, C; Pachler, K; Kreutzer, C; Zaunmair, P; Aigner, L; Rivera, FJ; Rohde, E; Benedetti, B; Gimona, M; Strunk, D; Couillard-Despres, S
TRANSFUS MED HEMOTH. 2017; 44: 76-76.
Abstracts (Zeitschrift)
Stepwise maturation of human iPSC into clonogenic immunosuppressive mesodermal stromal progenitors identifies key immunomodulatory pathways.
Scharler, C; Ketterl, N; Jürchott, K; Brachtl, G; Schallmoser, K; Volk, HD; Strunk, D
Human Gene Therapy. 2017; 28: A83-A84.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)

Unpublished conference presentations

Addressing skin with IVT mRNA
Hochmann, S; Mittermeir, M; Santic, R; Scharler, C; Scheiblhofer, S; Russe, E; Weiss, R; Mandler, M; Schneeberger, A; Strunk, D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
Human mesenchymal progenitors from non-skeletal adult sources display limited chondrogenic Differentiation.
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Geissler, S; Strunk, D
ISSCR Annual Meeting; 14.-17.06.2017; Boston. 2017.
No Identical Stromal Cells: Human Stromal Progenitors from Non-Skeletal Sources Display Limited Chondrogenic Potential
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Schmidt-Bleek, K; Ellinghaus, A; Geissler, S; Duda, G; Strunk, D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
Stepwise maturation of human iPSC into clonogenic immunosuppressive mesodermal stromal progenitors identifies key immunomodulatory pathways
Scharler, C; Ketterl, N; Jürchott, K; Brachtl, G; Schallmoser, K; Volk, HD; Strunk, D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.

2016

Journal Articles

Pleiotropic roles of the matricellular protein Sparc in tendon maturation and ageing.
Gehwolf, R; Wagner, A; Lehner, C; Bradshaw, AD; Scharler, C; Niestrawska, JA; Holzapfel, GA; Bauer, HC; Tempfer, H; Traweger, A;
Sci Rep. 2016; 6: 32635
Originalarbeiten (Zeitschrift)

Conference papers, proceedings, abstracts

Fibrinogen-Depleted Pooled Human Platelet Lysate for Efficient Expansion of Mesenchymal Stromal Cells
Öller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
Vox Sanguinis. 2016; 111(Suppl. 1):285--34th International Congress of the ISBT ; 03.-08.09.2016; Dubai.
Abstracts (Zeitschrift)
Efficient Expansion of Mesenchymal Stromal Cells by Fibrinogen-Depleted Pooled Human Platelet Lysate
Öller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
Transfusion Medicine and Hemotherapy. 2016; 43(Suppl.1):71--49. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie ; 07.-10.09.2016; Nürnberg.
Abstracts (Zeitschrift)
Calcipotriol treatment enhances wound closure and antimicrobial defense in recessive dystrophic epidermolysis bullosa in vitro while inhibiting proliferation and clonogenicity of RDEB cancer cells.
Tockner, B; Scharler, C; Huttner, C; Zurl, A; Strunk, D; Bauer, JW; Reichelt, J; Lang, R; Gruber, C; Hofbauer, JP
MOL BIOL CELL. 2016; 27:
Abstracts (Zeitschrift)

Unpublished conference presentations

MSPCs from non-skeletal adult sources have an altered chondrogenic regeneration potency.
Hochmann, S; Scharler, C; Textor, M; Brachtl, G; Föttinger, P; Hochreiter, A; Geissler, S; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Understanding the molecular landscape of human BM-derived MSPCs through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
PMU Science Day; 24.06.2016; Salzburg. 2016.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Daheron, L; Brachtl, G; Schallmoser, K; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Daheron, L; Brachtl, G; Schallmoser, K; Strunk, D
3rd PACT-Symposium: Designer Cells Go Clinic; 23.-24.09.2016; Wien. 2016.

2015

Journal Articles

A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance.
Ketterl, N; Brachtl, G; Schuh, C; Bieback, K; Schallmoser, K; Reinisch, A; Strunk, D;
Stem Cell Res Ther. 2015; 6: 236
Originalarbeiten (Zeitschrift)
Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9.
Lindner, M; Thümmler, K; Arthur, A; Brunner, S; Elliott, C; McElroy, D; Mohan, H; Williams, A; Edgar, JM; Schuh, C; Stadelmann, C; Barnett, SC; Lassmann, H; Mücklisch, S; Mudaliar, M; Schaeren-Wiemers, N; Meinl, E; Linington, C;
Brain. 2015; 138(Pt 7): 1875-1893.
Originalarbeiten (Zeitschrift)
The MAPK-Activated Kinase MK2 Attenuates Dendritic Cell-Mediated Th1 Differentiation and Autoimmune Encephalomyelitis.
Soukup, K; Halfmann, A; Le Bras, M; Sahin, E; Vittori, S; Poyer, F; Schuh, C; Luger, R; Niederreiter, B; Haider, T; Stoiber, D; Blüml, S; Schabbauer, G; Kotlyarov, A; Gaestel, M; Felzmann, T; Dohnal, AM;
J Immunol. 2015; 195(2): 541-552.
Originalarbeiten (Zeitschrift)

Unpublished conference presentations

Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
2nd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 05.11.2015; Salzburg. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
2nd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 05.11.2015; Salzburg. 2015.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk D.
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Attenuation of alloimmunity to human Endothelial Colony Forming Cells (ECFC) by interaction with Mesenchymal Stem/Progenitor Cells (MSPC) from umbilical cord.
Souidi, N; Rudeck, J; Stolk, M; Schmitt-Knosalla, I; Schuh, C; Schallmoser, K; Strunk, D; Volk, H-D; Seifert, M
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.

2014

Journal Articles

Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.
Schuh, C; Wimmer, I; Hametner, S; Haider, L; Van Dam, AM; Liblau, RS; Smith, KJ; Probert, L; Binder, CJ; Bauer, J; Bradl, M; Mahad, D; Lassmann, H;
Acta Neuropathol. 2014; 128(2): 247-266.
Originalarbeiten (Zeitschrift)

Unpublished conference presentations

U-derived stem/progenitor cells: A noninvasice cell source for regenerative purposes.
Brachtl, G; Schuh, C; Ketterl, N; Höfler, M; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014.
U-derived stem/progenitor cells: A noninvasice cell source for regenerative purposes.
Brachtl, G; Schuh, C; Ketterl, N; Höfler, M; Strunk, D
2nd International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.
Optimizing conditions to differentiate human induced pluripotent stem cells into mesenchymal stem/progenitor cells.
Höfler, M; Schuh, C; Ketterl, N; Brachtl, G; Strunk, D
International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.
Analyzing the immune modulation potential of human mesenchymal stem/progenitor cells.
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014. ; 13.11.2014; Salzburg. 2014.
Predicting and optimizing the immune modulation potential of human mesenchymal stem/progenitor cells.
Ketterl, N; Brachtl, G, Schuh, C; Schallmoser, K; Strunk, D
2nd International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Höfler, M; Ketterl, N; Brachtl, G; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014.